Michael J. Tan

482 total citations
21 papers, 237 citations indexed

About

Michael J. Tan is a scholar working on Epidemiology, Surgery and Infectious Diseases. According to data from OpenAlex, Michael J. Tan has authored 21 papers receiving a total of 237 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 6 papers in Surgery and 5 papers in Infectious Diseases. Recurrent topics in Michael J. Tan's work include Antibiotic Resistance in Bacteria (4 papers), Antimicrobial Resistance in Staphylococcus (4 papers) and Pneumonia and Respiratory Infections (3 papers). Michael J. Tan is often cited by papers focused on Antibiotic Resistance in Bacteria (4 papers), Antimicrobial Resistance in Staphylococcus (4 papers) and Pneumonia and Respiratory Infections (3 papers). Michael J. Tan collaborates with scholars based in United States, Canada and China. Michael J. Tan's co-authors include Thomas M. File, James S. Tan, Richard L. Oehler, Marcelo Cantarovich, Jean Tchervenkov, Timothy R. Pasquale, Antonio Di Carlo, Peter Metrakos, Lawrence Stein and Daniel S. Cowen and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Neurochemistry and Transplantation.

In The Last Decade

Michael J. Tan

17 papers receiving 226 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael J. Tan United States 9 72 67 65 41 32 21 237
Natalia Allende Argentina 6 19 0.3× 32 0.5× 36 0.6× 20 0.5× 17 0.5× 18 145
Márcia Halpern Brazil 11 59 0.8× 154 2.3× 113 1.7× 8 0.2× 17 0.5× 18 246
Sara Mazzanti Italy 9 28 0.4× 127 1.9× 164 2.5× 18 0.4× 7 0.2× 12 264
Gema Fresco Spain 8 46 0.6× 179 2.7× 175 2.7× 20 0.5× 7 0.2× 8 284
Elisa Vidal Spain 12 58 0.8× 147 2.2× 99 1.5× 21 0.5× 2 0.1× 21 295
Shilpi Agarwal India 7 19 0.3× 83 1.2× 16 0.2× 22 0.5× 34 1.1× 22 278
Shady Albakry United States 7 26 0.4× 131 2.0× 104 1.6× 171 4.2× 12 0.4× 8 310
Eric Levesque France 10 35 0.5× 134 2.0× 147 2.3× 12 0.3× 10 0.3× 15 258
Rosa Daza Spain 4 12 0.2× 100 1.5× 17 0.3× 18 0.4× 23 0.7× 7 155
Yeşim Çekın Türkiye 11 79 1.1× 115 1.7× 104 1.6× 50 1.2× 20 0.6× 36 397

Countries citing papers authored by Michael J. Tan

Since Specialization
Citations

This map shows the geographic impact of Michael J. Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Tan more than expected).

Fields of papers citing papers by Michael J. Tan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Tan. The network helps show where Michael J. Tan may publish in the future.

Co-authorship network of co-authors of Michael J. Tan

This figure shows the co-authorship network connecting the top 25 collaborators of Michael J. Tan. A scholar is included among the top collaborators of Michael J. Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael J. Tan. Michael J. Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tan, Michael J., Li Liu, Sacha Uljon, et al.. (2025). Rising illicit drug Adulterants: Xylazine and levamisole. Clinical Biochemistry. 137. 110912–110912.
2.
Okesanya, Olalekan John, Mohamed Mustaf Ahmed, Emery Manirambona, et al.. (2025). Reinvigorating AMR resilience: leveraging CRISPR–Cas technology potentials to combat the 2024 WHO bacterial priority pathogens for enhanced global health security—a systematic review. Tropical Medicine and Health. 53(1). 43–43. 12 indexed citations
3.
Lucero‐Prisno, Don Eliseo, Olalekan John Okesanya, Mohamed Mustaf Ahmed, et al.. (2025). Emerging technologies and innovative approaches to combat antimicrobial resistance: A narrative review of next-generation therapeutic strategies. Research at York St John (York St John University). 1. 100003–100003.
4.
Li, Ying, Ziming Li, Chaochao Chen, et al.. (2025). Colorectal cancer cells hijack a brain–gut polysynaptic circuit from the lateral septum to enteric neurons to sustain tumor growth. Nature Cancer. 6(11). 1800–1820.
5.
Neelankavil, Jacques, Reed Harvey, Jure Marijic, et al.. (2024). Incidence and Risk Factors for Clinically Significant Oropharyngeal Dysphagia After Lung Transplantation. Transplantation Proceedings. 56(10). 2226–2230. 1 indexed citations
6.
Nielsen, Craig, et al.. (2022). Update on pneumococcal vaccination in adults: Simpler is better.. PubMed. 89(11). 640–642. 1 indexed citations
7.
File, Thomas M., et al.. (2017). Effect of Rapid Molecular Diagnostic Testing and Antimicrobial Stewardship on Antimicrobial Therapy of Respiratory Infections. Open Forum Infectious Diseases. 4(suppl_1). S628–S629. 2 indexed citations
8.
Pasquale, Timothy R., et al.. (2014). Impact of an antimicrobial stewardship program on patients with acute bacterial skin and skin structure infections. American Journal of Health-System Pharmacy. 71(13). 1136–1139. 22 indexed citations
9.
Boone, James H., et al.. (2013). Elevated lactoferrin is associated with moderate to severe Clostridium difficile disease, stool toxin, and 027 infection. European Journal of Clinical Microbiology & Infectious Diseases. 32(12). 1517–1523. 31 indexed citations
10.
Pasquale, Timothy R., et al.. (2013). Methicillin-resistantStaphylococcus aureusnosocomial pneumonia patients treated with ceftaroline: retrospective case series of 10 patients. Journal of Chemotherapy. 27(1). 29–34. 20 indexed citations
11.
Tan, Michael J., et al.. (2009). Hypokalemia Associated With Nafcillin Treatment. Infectious Diseases in Clinical Practice. 17(2). 130–131. 1 indexed citations
12.
Tan, Michael J.. (2008). Staphylococcus aureus Enterocolitis. Infectious Diseases in Clinical Practice. 16(4). 207–208. 2 indexed citations
13.
Tan, Michael J. & Richard L. Oehler. (2005). Lower Extremity Cellulitis and Bacteremia With Herbaspirillum seropedicae Associated With Aquatic Exposure in a Patient With Cirrhosis. Infectious Diseases in Clinical Practice. 13(5). 277–279. 19 indexed citations
14.
Tan, Michael J., et al.. (2002). Reduced dose Thymoglobulin®, tacrolimus, and mofetil mycophenolate results in excellent solitary pancreas transplantation outcomes. Clinical Transplantation. 16(6). 414–418. 10 indexed citations
15.
Tan, Michael J., Antonio Di Carlo, Shu Liu, et al.. (2002). Hepatic Sinusoidal Endothelium Upregulates IL-1α, IFN-γ, and iNOS in Response to Discordant Xenogeneic Islets in an in Vitro Model of Xenoislet Transplantation. Journal of Surgical Research. 102(2). 229–236. 5 indexed citations
16.
Tan, Michael J., James S. Tan, & Thomas M. File. (2002). Legionnaires Disease with Bacteremic Coinfection. Clinical Infectious Diseases. 35(5). 533–539. 33 indexed citations
17.
Tan, Michael J., et al.. (2001). Successful outcome after transplantation of a donor liver with focal nodular hyperplasia. Liver Transplantation. 7(7). 652–655. 2 indexed citations
18.
Tan, Michael J., Antonio Di Carlo, Lawrence Stein, et al.. (2001). PSEUDOANEURYSM OF THE SUPERIOR MESENTERIC ARTERY AFTER PANCREAS TRANSPLANTATION TREATED BY ENDOVASCULAR STENTING. Transplantation. 72(2). 336–338. 42 indexed citations
19.
Fischer, Peter, et al.. (2000). Limbusnahe Entlastungsschnitte zur Astigmatismusreduktion im Rahmen der Kataraktchirurgie1. Klinische Monatsblätter für Augenheilkunde. 217(5). 257–262. 7 indexed citations
20.
Tan, Michael J., et al.. (1998). Coupling of Serotonin 5‐HT1B Receptors to Activation of Mitogen‐Activated Protein Kinase (ERK‐2) and p70 S6 Kinase Signaling Systems. Journal of Neurochemistry. 71(3). 1059–1067. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Natalia Allende Breakdown of academic impact, for papers by Márcia Halpern Breakdown of academic impact, for papers by Sara Mazzanti Breakdown of academic impact, for papers by Gema Fresco Breakdown of academic impact, for papers by Elisa Vidal Breakdown of academic impact, for papers by Shilpi Agarwal Breakdown of academic impact, for papers by Shady Albakry Breakdown of academic impact, for papers by Eric Levesque Breakdown of academic impact, for papers by Rosa Daza Breakdown of academic impact, for papers by Yeşim Çekın
Rankless by CCL
2026